Revance Therapeutics
RVNC
#6432
Rank
NZ$0.90 B
Marketcap
$8.66
Share price
-0.56%
Change (1 day)
-54.72%
Change (1 year)

Market capitalization of Revance Therapeutics (RVNC)

Market cap: NZ$0.90 Billion

As of September 2024 Revance Therapeutics has a market cap of NZ$0.90 Billion. This makes Revance Therapeutics the world's 6432th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$0.90 B-26.05%
2023NZ$1.22 B-48.98%
2022NZ$2.39 B39.82%
2021NZ$1.71 B-34.76%
2020NZ$2.62 B108.1%
2019NZ$1.26 B13.62%
2018NZ$1.10 B-39.4%
2017NZ$1.83 B114.79%
2016NZ$0.85 B-39.71%
2015NZ$1.41 B175.33%
2014NZ$0.51 B

End of Day market cap according to different sources

On Sep 29th, 2024 the market cap of Revance Therapeutics was reported to be:

NZ$0.90 Billion
by Yahoo Finance info icon info icon
NZ$0.90 Billion
by CompaniesMarketCap info icon info icon
NZ$0.90 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$0.15 B-83.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$628.00 B 69,477.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$45.83 B 4,977.99%๐Ÿ‡บ๐Ÿ‡ธ USA